Team Leader

Dr. Tian Xiaoli (MD, PH.D.) is the founder and chief executive of YiHao Biology. She has 15 years of overseas study and work experience, and her professional field involves tumor immunity and virus immunity. She was a student of Arie Belldegrun, the founder of CAR-T leader Kite Pharma, and has extensive experience in the development of CAR-T, TCR-T, and DC vaccine. In 2013, she returned to China from the University of California to start her own business and founded a number of emerging bio companies and applied for several dozens of national invention patents. She won the first prize of “China (Dalian) Overseas Engineering Entrepreneurship Competition”. In 2017, She became Vice Chairman of the Translational Medicine Branch of the European and American Alumni Association.